Search
AMZ002
go.drugbank.com/drugs/DB17017InvestigationalAMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.
Vintafolide
go.drugbank.com/drugs/DB05168InvestigationalVintafolide is a folate-targeted chemotherapeutic conjugate (folate vitamin + vinca alkaloid) in clinical stage development as a treatment for folate-receptor positive cancers.
Phosphonoacetic Acid
go.drugbank.com/drugs/DB02823ExperimentalA simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. [PubChem]
ATX-101
go.drugbank.com/drugs/DB05780InvestigationalDeoxycholic acid is a naturally occurring bile acid produced by the liver as one of several end products of cholesterol metabolism. … ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits.
Nifurizone
go.drugbank.com/drugs/DB19694ExperimentalNifurizone has a monoisotopic molecular weight of 307.09 Da.
Onametostat
go.drugbank.com/drugs/DB21480InvestigationalOnametostat has a monoisotopic molecular weight of 482.11 Da.
Nifurethazone
go.drugbank.com/drugs/DB20112ExperimentalNifurethazone has a monoisotopic molecular weight of 269.11 Da.
Gamcemetinib
go.drugbank.com/drugs/DB21624InvestigationalGamcemetinib has a monoisotopic molecular weight of 469.1 Da.
Pumactant
go.drugbank.com/drugs/DB04955ExperimentalPumactant is a synthetic surfactant used for treating respiratory distress syndrome in neonates. It is a unique formulation of the naturally occurring phospholipids Dipalmitoylphosphatidycholine (DPPC) and Phosphatidyl Glycerol (PG).
Dirucotide
go.drugbank.com/drugs/DB04921InvestigationalDirucotide has been developed for the treatment of multiple sclerosis (MS). Developed at the University of Alberta, dirucotide is being investigated by BioMS Medical Corp.